Arkolith/Insider Trading/AVDL/Form 4

Divis Gregory J

Chief Executive Officer, DirectorAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Feb 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
2 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Disposed to issuer(D)10K$21.00$210K0
Feb 12, 2026Disposed to issuer(D)211K$21.00$4.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2026Disposed to issuer(D)50K——0
Feb 12, 2026Disposed to issuer(D)100K——0
Feb 12, 2026Disposed to issuer(D)400K——0
Feb 12, 2026Disposed to issuer(D)500K——0
Feb 12, 2026Disposed to issuer(D)150K——0
Feb 12, 2026Disposed to issuer(D)350K——0
Feb 12, 2026Disposed to issuer(D)600K——0
Feb 12, 2026Disposed to issuer(D)310K——0
Feb 12, 2026Disposed to issuer(D)100K——0
Feb 12, 2026Disposed to issuer(D)310K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-014441) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML